Fast Pace Medical Clinic Pllc - Medicare Primary Care in Hanover, IN

Fast Pace Medical Clinic Pllc is a medicare enrolled primary clinic (Family Medicine) in Hanover, Indiana. The current practice location for Fast Pace Medical Clinic Pllc is 4152 W State Road, Hanover, Indiana. For appointments, you can reach them via phone at (931) 253-1110. The mailing address for Fast Pace Medical Clinic Pllc is Po Box 1258, Waynesboro, Tennessee and phone number is (931) 253-1110.

Fast Pace Medical Clinic Pllc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1649770769. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (931) 253-1110.

Contact Information

Fast Pace Medical Clinic Pllc
4152 W State Road
Hanover
IN 47243
(931) 253-1110
(931) 722-9919

Primary Care Clinic Profile

Full NameFast Pace Medical Clinic Pllc
SpecialityFamily Medicine
Location4152 W State Road, Hanover, Indiana
Authorized Official Name and PositionRobert Benson (COO)
Authorized Official Contact9312531110
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Fast Pace Medical Clinic Pllc
Po Box 1258
Waynesboro
TN 38485-1258

Ph: (931) 253-1110
Fast Pace Medical Clinic Pllc
4152 W State Road
Hanover
IN 47243

Ph: (931) 253-1110

NPI Details:

NPI Number1649770769
Provider Enumeration Date02/15/2018
Last Update Date03/11/2024

Medicare PECOS Information:

Medicare PECOS PAC ID5395881841
Medicare Enrollment IDO20200827001491

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for Fast Pace Medical Clinic Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1649770769NPI-NPPES
300036022MedicaidIN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary
261QU0200XClinic/center - Urgent Care (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Fast Pace Medical Clinic Pllc acts as a billing entity for following providers:
Provider NameLori D Duggins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1457352635
PECOS PAC ID: 8921087172
Enrollment ID: I20040720000479

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDonna Jean Eve
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1891799730
PECOS PAC ID: 5597735498
Enrollment ID: I20040914001436

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMichael C Harper
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1487615415
PECOS PAC ID: 7113939133
Enrollment ID: I20060612000145

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameRichard J Bobay
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881732881
PECOS PAC ID: 6406916238
Enrollment ID: I20081125000071

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTanya Ruth Reynolds
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407954696
PECOS PAC ID: 6406905223
Enrollment ID: I20090527000078

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAnn Marie Vash
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154553196
PECOS PAC ID: 8628118809
Enrollment ID: I20091218000409

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLou C Kline
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1932424652
PECOS PAC ID: 7517099534
Enrollment ID: I20100709000383

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJennifer A Barnes
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1710284526
PECOS PAC ID: 0547442808
Enrollment ID: I20110308000214

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTara A Mendoza
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366742488
PECOS PAC ID: 0648455840
Enrollment ID: I20110504000182

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMichelle D Meyer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861778763
PECOS PAC ID: 6204000920
Enrollment ID: I20111115000504

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameBarry Louis Taylor
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1316292956
PECOS PAC ID: 1456256494
Enrollment ID: I20120920000793

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDonna M Everman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1821343500
PECOS PAC ID: 8729238209
Enrollment ID: I20121017000918

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKristin M Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1003165275
PECOS PAC ID: 7911151238
Enrollment ID: I20130213000454

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJanelle L Meade
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962719351
PECOS PAC ID: 1557540549
Enrollment ID: I20130730000913

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameVickie Lynn Emberton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1730529413
PECOS PAC ID: 4082858741
Enrollment ID: I20130918000782

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTina M Woodrome-nethery
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962759274
PECOS PAC ID: 4183872021
Enrollment ID: I20140326002168

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMelissa A Pyatskowit
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154673820
PECOS PAC ID: 5698908010
Enrollment ID: I20140512001383

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHolly Laue
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1255743076
PECOS PAC ID: 0648495549
Enrollment ID: I20140709001985

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLaura Sparks
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972912376
PECOS PAC ID: 9032338728
Enrollment ID: I20140911000305

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMinsun Kim
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205225554
PECOS PAC ID: 2668796137
Enrollment ID: I20150112001154

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJeffrey Coy
Provider TypePractitioner - Certified Clinical Nurse Specialist (cns)
Provider IdentifiersNPI Number: 1447494893
PECOS PAC ID: 3274507579
Enrollment ID: I20150626001455

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameRebecca E Waugh
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962888677
PECOS PAC ID: 7113233990
Enrollment ID: I20150825005093

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMelissa A Johnston
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851794374
PECOS PAC ID: 1153643903
Enrollment ID: I20151013000057

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJill S Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871758904
PECOS PAC ID: 1557439213
Enrollment ID: I20151027000199

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTara L Pearcy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1770952897
PECOS PAC ID: 0941500557
Enrollment ID: I20151204000267

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmber L Graber
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649649781
PECOS PAC ID: 2668779596
Enrollment ID: I20160321001470

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCrystal Nicole Kennedy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1902267057
PECOS PAC ID: 1850699752
Enrollment ID: I20160408001611

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLeann E. Guerra
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1093171829
PECOS PAC ID: 5496044315
Enrollment ID: I20160517000992

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJulie Crowe
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1730496563
PECOS PAC ID: 6608038658
Enrollment ID: I20160902001376

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NamePriscilla Rasaki
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760841548
PECOS PAC ID: 7810296563
Enrollment ID: I20161128001136

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameElizabeth A Sanders
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1053861195
PECOS PAC ID: 5597047209
Enrollment ID: I20170112001938

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLora E Marshall
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871032045
PECOS PAC ID: 4284911298
Enrollment ID: I20170501000094

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTonya M Whitaker
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881128536
PECOS PAC ID: 4587932744
Enrollment ID: I20170613001397

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmber N Handshoe
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073034500
PECOS PAC ID: 5496025611
Enrollment ID: I20170720003060

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCharlotte Claire Waling
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1831610740
PECOS PAC ID: 6901170695
Enrollment ID: I20170919002238

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameErin E Diem
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1588190755
PECOS PAC ID: 1658637590
Enrollment ID: I20171109002756

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKasey J Hollenbach
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760864169
PECOS PAC ID: 8325354152
Enrollment ID: I20180222002191

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTimothy Wise
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1467949073
PECOS PAC ID: 6204190283
Enrollment ID: I20180426002577

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameIsrael Nieto
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952890352
PECOS PAC ID: 6800151028
Enrollment ID: I20180517001097

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCassie Hackman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1750886966
PECOS PAC ID: 8820345861
Enrollment ID: I20180720002451

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCody R Stein
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1346745619
PECOS PAC ID: 2264789866
Enrollment ID: I20180726002518

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmy Allison Sites
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104302744
PECOS PAC ID: 2961750260
Enrollment ID: I20180802002011

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMichelle C Mercier
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134601552
PECOS PAC ID: 5294086385
Enrollment ID: I20181001000087

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMiranda Cassity
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1841772472
PECOS PAC ID: 3971855909
Enrollment ID: I20181002003300

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameBridjett Gassaway
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194291526
PECOS PAC ID: 8123363652
Enrollment ID: I20190102002177

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameRebecca Joy Groen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073070009
PECOS PAC ID: 1254671993
Enrollment ID: I20190318000156

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMary Jacqueline Wharton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1992265904
PECOS PAC ID: 8224370465
Enrollment ID: I20190508002091

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDanielle R Hollenbeck
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659855310
PECOS PAC ID: 3577805746
Enrollment ID: I20190509000051

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJennifer Lee Scales
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1982162723
PECOS PAC ID: 7113166695
Enrollment ID: I20190522003152

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmber Hart
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104480235
PECOS PAC ID: 6305173253
Enrollment ID: I20190815000113

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameRebecca Chantelois
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1992362131
PECOS PAC ID: 1557699618
Enrollment ID: I20190827003313

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDebra A Taylor
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1245792522
PECOS PAC ID: 8527391416
Enrollment ID: I20191126002372

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTobey Gilmore
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134770167
PECOS PAC ID: 2769815380
Enrollment ID: I20191211002801

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameGinger M Richard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1093352130
PECOS PAC ID: 8224462460
Enrollment ID: I20191223000603

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDawn K Sirek
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760944797
PECOS PAC ID: 6002243110
Enrollment ID: I20200303000838

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJessica Lynn Haviland
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1538792668
PECOS PAC ID: 7719315977
Enrollment ID: I20200322000113

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJohn Houston
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1386793008
PECOS PAC ID: 1557441144
Enrollment ID: I20200724002403

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMelanie Josephine Pickett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1902417686
PECOS PAC ID: 5890113195
Enrollment ID: I20200918001337

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJessica E Arwood
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1912513896
PECOS PAC ID: 6204246515
Enrollment ID: I20201027002649

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLisa Marie Lee
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1568083038
PECOS PAC ID: 4284044462
Enrollment ID: I20201028002547

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameFelicia Marie Owen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1386232429
PECOS PAC ID: 1355755752
Enrollment ID: I20210126002360

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameNicole Renee Quainoo
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104418904
PECOS PAC ID: 7214343201
Enrollment ID: I20210317002374

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLacey Youhas
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1669934865
PECOS PAC ID: 2567704943
Enrollment ID: I20210713000550

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmanda Baskin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1639563794
PECOS PAC ID: 4789923152
Enrollment ID: I20210806001669

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAmber D Raeth
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043988975
PECOS PAC ID: 5193113173
Enrollment ID: I20211025000379

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCamille Mae Carl
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1730788720
PECOS PAC ID: 3072927649
Enrollment ID: I20211101001132

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJennifer Sue Mendel
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225706013
PECOS PAC ID: 0547658908
Enrollment ID: I20211104000639

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLyndia Henson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972265817
PECOS PAC ID: 9931598125
Enrollment ID: I20211109002259

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDesiree Fawn Craig
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962167551
PECOS PAC ID: 3870982028
Enrollment ID: I20211110000943

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameSarah Enlow
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639838824
PECOS PAC ID: 8527459007
Enrollment ID: I20211216000847

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMelissa Ritchie
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1477212231
PECOS PAC ID: 2961895677
Enrollment ID: I20220201002306

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameShauna Gish
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306940762
PECOS PAC ID: 9537168646
Enrollment ID: I20220302002114

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAbby N Strong
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1891442042
PECOS PAC ID: 4486040235
Enrollment ID: I20220405001125

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJennifer Coffin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1063065209
PECOS PAC ID: 7810228335
Enrollment ID: I20220426001316

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKimberly Burrus
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1770228306
PECOS PAC ID: 8224425848
Enrollment ID: I20220429001500

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHaleigh Jordan Nidlinger
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356011266
PECOS PAC ID: 6709263882
Enrollment ID: I20220510002610

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKellee Perry
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154073963
PECOS PAC ID: 1850770249
Enrollment ID: I20220615000346

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameDanielle Carpenter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609434539
PECOS PAC ID: 8527492636
Enrollment ID: I20220701001622

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCharles R Melton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811462146
PECOS PAC ID: 5092053587
Enrollment ID: I20220711002050

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTeresa Kinney
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609178987
PECOS PAC ID: 6305035783
Enrollment ID: I20220711002488

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMelissa Wilkerson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144854456
PECOS PAC ID: 8224417837
Enrollment ID: I20220907003294

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameSarah Rudkosky
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1457079758
PECOS PAC ID: 1355725474
Enrollment ID: I20220908001157

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameNathan Reed Hughes
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326777152
PECOS PAC ID: 7214312735
Enrollment ID: I20220920002777

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMarti Wagers
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639892136
PECOS PAC ID: 2163808163
Enrollment ID: I20220928002237

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAustin Watkins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1255840492
PECOS PAC ID: 5092131631
Enrollment ID: I20221005002161

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLisa Ruth May
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548984248
PECOS PAC ID: 3072989201
Enrollment ID: I20221013000725

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLauren Nicole Shewman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184334922
PECOS PAC ID: 9830568005
Enrollment ID: I20221209001343

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameColby Morgan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295406551
PECOS PAC ID: 3375912314
Enrollment ID: I20221213002717

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKarlee Stamey
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164976593
PECOS PAC ID: 9335436435
Enrollment ID: I20221216001519

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameRenee Marie Goodrich
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124750815
PECOS PAC ID: 6901276104
Enrollment ID: I20230104002705

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameChad Reynolds
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649981580
PECOS PAC ID: 2769852599
Enrollment ID: I20230112000152

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJulie Elizabeth Myers
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295449437
PECOS PAC ID: 8325419039
Enrollment ID: I20230117001167

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHaley L Mifflin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639885791
PECOS PAC ID: 6608247713
Enrollment ID: I20230128000331

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameFidelity Ageh Akonji
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1598462939
PECOS PAC ID: 8820460942
Enrollment ID: I20230217001170

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameIrene M Nzuki
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1285340455
PECOS PAC ID: 4981077047
Enrollment ID: I20230310001706

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameAndrea Marie Maley
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205546959
PECOS PAC ID: 9537533450
Enrollment ID: I20230316000435

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameMisty Dawn Bozarth
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1598467896
PECOS PAC ID: 7517331788
Enrollment ID: I20230330001032

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHayley Bussey
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1285324962
PECOS PAC ID: 0941666358
Enrollment ID: I20230509002564

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTakeyah Rosenthall
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1275218083
PECOS PAC ID: 8123486123
Enrollment ID: I20230623001065

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKayla Richter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679259030
PECOS PAC ID: 7113386723
Enrollment ID: I20230629002570

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTrisha Darling
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1700548369
PECOS PAC ID: 8123483450
Enrollment ID: I20230721002075

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameTara Engel
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1780363572
PECOS PAC ID: 5698136539
Enrollment ID: I20230725003282

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameSheena Lee
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1497449961
PECOS PAC ID: 6709240492
Enrollment ID: I20230913004121

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJulie Coulson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1386893147
PECOS PAC ID: 8527124940
Enrollment ID: I20230915002359

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKara Jean Wilson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013794130
PECOS PAC ID: 7012361306
Enrollment ID: I20230920001439

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJayma Marie Bauer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619613825
PECOS PAC ID: 6507212396
Enrollment ID: I20231031001467

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameJulia Bouse
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649044520
PECOS PAC ID: 9830546654
Enrollment ID: I20231115002354

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKelly Schoon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134996390
PECOS PAC ID: 3779932785
Enrollment ID: I20231214003680

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameLauren Kay Carlisle
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184811069
PECOS PAC ID: 9638528664
Enrollment ID: I20231215000300

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameCameron Kitchell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1114601267
PECOS PAC ID: 2961852132
Enrollment ID: I20231229002421

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHeather Myree Anderson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962279216
PECOS PAC ID: 2668824806
Enrollment ID: I20240123003742

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameKristin Steed
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1063273324
PECOS PAC ID: 2567815418
Enrollment ID: I20240127000559

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameHaley Holscher
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1932961893
PECOS PAC ID: 3173966223
Enrollment ID: I20240206003322

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

Provider NameElizabeth Anne Mysliwiec
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013640200
PECOS PAC ID: 0749624724
Enrollment ID: I20240217000351

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more Medical News

› Verified 6 days ago

News Archive

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

New policy sets nutrition standards for food and beverages sold in Ontario schools

ARAMARK Canada Ltd., a leader in providing professional food services to more than 150 middle and high schools across Ontario, is in full support of the Ontario Ministry of Education's Policy Memorandum No. 150, School Food and Beverage Policy, setting nutrition standards for food and beverages sold in publicly funded elementary and secondary schools in Ontario.

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

Breakthrough reveals first ever complete structure of a nuclear hormone receptor on human DNA

For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol.

Excluded from WHO targets, children at risk of being forgotten in global NCD agenda

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her "Global Health Blog," writing, "Children die from cancer, heart disease and other NCDs but they are in danger of being forgotten as global targets for action are drawn up, say health groups."

Read more News

› Verified 6 days ago


Family Medicine in Hanover, IN


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.